Establishment Labs Holdings, Inc. (ESTA) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

TransMedics Group, Inc.

LeMaitre Vascular, Inc.

PROCEPT BioRobotics Corp.

Veracyte, Inc.

NovoCure Ltd.

Establishment Labs Holdings, Inc.

Tandem Diabetes Care, Inc.

Alphatec Holdings, Inc.

STAAR Surgical Co.

Myriad Genetics, Inc.

Owens & Minor, Inc.

Why is Establishment Labs Holdings, Inc. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate -157.40% of over the last 5 years
Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
RAW MATERIAL COST(Y) Fallen by -4.91% (YoY)
NET SALES(Q) Highest at USD 51.3 MM
PRE-TAX PROFIT(Q) Highest at USD -15.59 MM

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 51.48%, its profits have fallen by -7.7%

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Market Beating Performance

The stock has generated a return of 51.48% in the last 1 year, much higher than market (S&P 500) returns of 12.33%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Establishment Labs Holdings, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Establishment Labs Holdings, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Establishment Labs Holdings, Inc.

59.15%

0.53

79.34%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

16.67%

EBIT Growth (5y)

-157.40%

EBIT to Interest (avg)

-3.08

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

3.96

Sales to Capital Employed (avg)

0.73

Tax Ratio

0.50%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

28.91

EV to EBIT

-21.81

EV to EBITDA

-25.67

EV to Capital Employed

6.62

EV to Sales

7.44

PEG Ratio

Dividend Yield

ROCE (Latest)

-30.38%

ROE (Latest)

-231.14%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.91% (YoY

NET SALES(Q)

Highest at USD 51.3 MM

PRE-TAX PROFIT(Q)

Highest at USD -15.59 MM

NET PROFIT(Q)

Highest at USD -16.59 MM

EPS(Q)

Highest at USD -0.57

-6What is not working for the Company

NET PROFIT(9M)

At USD -71.83 MM has Grown at -33.21%

INTEREST(9M)

At USD 17.76 MM has Grown at 27.71%

CASH AND EQV(HY)

Lowest at USD 123.82 MM

Here's what is working for Establishment Labs Holdings, Inc.

Net Sales

Highest at USD 51.3 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Net Sales

At USD 51.3 MM has Grown at 20.54%

over average net sales of the previous four periods of USD 42.56 MM

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Pre-Tax Profit

Highest at USD -15.59 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -16.59 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD -0.57

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -4.91% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at USD 2.6 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Establishment Labs Holdings, Inc.

Interest

At USD 17.76 MM has Grown at 27.71%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Cash and Eqv

Lowest at USD 123.82 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents